The Goldman Sachs Group, Inc. 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 3:34 pm Sale | 2025-09-30 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | GOLDMAN SACHS GROUP INC GS | 132 0.000% | -4,233,901 (-100.00%) | Filing |
| 2025-08-13 5:25 pm Purchase | 2025-06-30 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | GOLDMAN SACHS GROUP INC GS | 4,234,033 5.600% | 4,234,033 (New Position) | Filing |